{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:38:04Z","timestamp":1784299084541,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.chest.2021.02.052","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T11:11:54Z","timestamp":1614683514000},"page":"351-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Breathlessness Predicts Survival in Patients With Malignant Pleural Effusions"],"prefix":"10.1016","volume":"160","author":[{"given":"Eleanor K.","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeevan","family":"Muruganandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. C. Gary","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najib M.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.chest.2021.02.052_bib1","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs\u00a0chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1016\/j.chest.2021.02.052_bib2","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","article-title":"Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.chest.2021.02.052_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2018-000368","volume":"6","author":"Matthews","year":"2019","journal-title":"BMJ Open Respir Res"},{"issue":"6","key":"10.1016\/j.chest.2021.02.052_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/crj.12292","article-title":"Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions","volume":"10","author":"Kasapoglu","year":"2016","journal-title":"Clin Respir J"},{"key":"10.1016\/j.chest.2021.02.052_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12890-015-0025-z","article-title":"Important prognostic factors for survival in patients with malignant pleural effusion","volume":"15","author":"Zamboni","year":"2015","journal-title":"BMC Pulm Med"},{"issue":"26","key":"10.1016\/j.chest.2021.02.052_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003996","article-title":"Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion","volume":"95","author":"Verma","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.chest.2021.02.052_bib7","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.chest.2021.02.052_bib8","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1470-2045(18)30294-8","article-title":"Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis","volume":"19","author":"Psallidas","year":"2018","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.chest.2021.02.052_bib9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000489315","article-title":"An observational study evaluating the performance of LENT score in the selected population of malignant pleural effusion from lung adenocarcinoma in Singapore","volume":"96","author":"Abisheganaden","year":"2018","journal-title":"Respiration"},{"key":"10.1016\/j.chest.2021.02.052_bib10","first-page":"A133","article-title":"Evaluation of the LENT and PROMISE score for malignant pleural mesothelioma by histological subtype","volume":"74","author":"Banka","year":"2019","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.chest.2021.02.052_bib11","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/resp.13837","article-title":"Malignant pleural effusion survival prognostication in an Asian population","volume":"25","author":"Quek","year":"2020","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.chest.2021.02.052_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.rmed.2007.11.008","article-title":"The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis","volume":"102","author":"Manali","year":"2008","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.chest.2021.02.052_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1751-7133.2009.00107.x","article-title":"Maximal dyspnea on exertion during cardiopulmonary exercise testing is related to poor prognosis and echocardiography with tissue Doppler imaging in heart failure","volume":"15","author":"Guazzi","year":"2009","journal-title":"Congest Heart Fail"},{"issue":"1","key":"10.1016\/j.chest.2021.02.052_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ehf2.12371","article-title":"Patterns of dyspnoea onset in patients with acute heart failure: clinical and prognostic implications","volume":"6","author":"Sokolska","year":"2019","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10.1016\/j.chest.2021.02.052_bib15","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/(SICI)1097-0142(19960915)78:6<1314::AID-CNCR21>3.0.CO;2-2","article-title":"Dyspnea in cancer patients: etiology, resource utilization, and survival-implications in a managed care world","volume":"78","author":"Escalante","year":"1996","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.chest.2021.02.052_bib16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021322","article-title":"The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease","volume":"350","author":"Celli","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.chest.2021.02.052_bib17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/crj.12191","article-title":"Dyspnea as an independent predictor of mortality","volume":"10","author":"Pesola","year":"2016","journal-title":"Clin Respir J"},{"issue":"1","key":"10.1016\/j.chest.2021.02.052_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13665-016-0130-3","article-title":"Measurement of breathlessness in patients with malignant pleural effusions","volume":"5","author":"Mishra","year":"2016","journal-title":"Curr Pulmonol Rep"},{"issue":"4","key":"10.1016\/j.chest.2021.02.052_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123798","article-title":"Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions","volume":"10","author":"Mishra","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.chest.2021.02.052_bib20","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1164\/rccm.201704-0809OC","article-title":"Randomized controlled trial of urokinase versus placebo for nondraining malignant pleural effusion","volume":"197","author":"Mishra","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"14","key":"10.1016\/j.chest.2021.02.052_bib21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1716883","article-title":"Outpatient talc administration by indwelling pleural catheter for malignant effusion","volume":"378","author":"Bhatnagar","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.chest.2021.02.052_bib22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","article-title":"Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial","volume":"6","author":"Muruganandan","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"19","key":"10.1016\/j.chest.2021.02.052_bib23","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2017.17426","article-title":"Effect of an indwelling pleural catheter vs\u00a0talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial","volume":"318","author":"Thomas","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.chest.2021.02.052_bib24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa1012740","article-title":"Intrapleural use of tissue plasminogen activator and DNase in pleural infection","volume":"365","author":"Rahman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2021.02.052_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12325-019-01128-9","article-title":"Dyspnea in COPD: new mechanistic insights and management implications","volume":"37","author":"O\u2019Donnell","year":"2020","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.chest.2021.02.052_bib26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000029240","article-title":"Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases","volume":"65","author":"Martinez-Moragon","year":"1998","journal-title":"Respiration"},{"issue":"9","key":"10.1016\/j.chest.2021.02.052_bib27","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.rmed.2005.02.022","article-title":"Etiology and prognostic significance of massive pleural effusions","volume":"99","author":"Jimenez","year":"2005","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.chest.2021.02.052_bib28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/resp.13681","article-title":"Inter-observer variation in image interpretation and the prognostic importance of non-expansile lung in malignant pleural effusion","volume":"25","author":"Martin","year":"2020","journal-title":"Respirology"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221004529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221004529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:37:18Z","timestamp":1757925438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369221004529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0012369221004529"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.02.052","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breathlessness Predicts Survival in Patients With Malignant Pleural Effusions","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.02.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}